# CRB

With autologous cell therapies facing unsustainable COGS, US-based engineering firms (like CRB and IPS) are pioneering TEA models that simulate the financial impact of decentralized, "hospital-adjacent" manufacturing networks.

Source: https://en.bioecon.ru/companies/crb/
Updated: 2026-06-24

- Country: United States

## Technologies

- [Techno-economic analysis (TEA) for bioprocesses](https://en.bioecon.ru/technology/techno-economic-analysis-tea-bioprocesses/)